State officials' apparent contradictory statements leave Fairhope officials searching for answers about sudden loss of ...

Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...

The Fairhope Public Library Board will decide whether to review books deemed "sexually explicit" by the Alabama Public ...

Less than two weeks after having its funding temporarily cut by the state, the Fairhope Public Library is getting recognized ...

Wahl provided a federal definition of "sexually explicit conduct" that doesn't appear to apply to written content.

Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has accepted and granted Priority Review designation ...

The Alabama Public Library Service (APLS) voted to pause $40,000 in funding to the Fairhope Public Library after the ...

In trading on Monday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) entered into oversold territory, hitting an RSI reading of 26.7, after changing hands as low as $21.89 per share.

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

Investors in Apellis Pharmaceuticals Inc (Symbol: APLS) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

The National Population Commission (NPC) has called for increased collaboration among stakeholders to tackle Nigeria’s ...